Related Experiment Video

Updated: Jun 21, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Exploring Rak tyrosine kinase function in breast cancer

Eun-Kyoung Yim1, Stefan Siwko, Shiaw-Yih Lin

  • 1Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.

Cell Cycle (Georgetown, Tex.)
|July 15, 2009
PubMed

Insights

Rak, a nuclear tyrosine kinase, acts as a tumor suppressor by regulating PTEN. Its loss promotes cancer, highlighting its potential as a therapeutic target in Rak-defective cancers.

Area of Science:

  • Molecular biology
  • Cellular signaling
  • Cancer research

Background:

  • Protein tyrosine kinases regulate crucial cellular events, and their deregulation is linked to human cancer.
  • Most known tyrosine kinases are membrane-bound, involved in signal transduction.
  • A subset of nuclear tyrosine kinases, including Rak, has been identified.

Purpose of the Study:

  • To investigate the role of the nuclear tyrosine kinase Rak in cancer.
  • To explore Rak's function in regulating PTEN protein stability and activity.
  • To understand Rak's impact on cancer cell phenotypes and tumorigenicity.

Main Methods:

  • Investigated Rak's tumor suppressor activity.
  • Assessed Rak's regulation of PTEN protein stability and function.
  • Studied the effects of Rak depletion on breast cancer cell transformation and tumorigenicity in vivo.

Main Results:

  • Rak functions as a potent tumor suppressor.
  • Rak regulates PTEN protein stability and function.
  • Rak suppresses in vitro transformation and in vivo tumorigenicity in breast cancer cells.
  • Depletion of Rak induces tumorigenicity in mammary epithelial cells.

Conclusions:

  • Rak is a critical tumor suppressor.
  • Understanding Rak's mechanisms offers potential therapeutic targets for Rak-defective cancers.
  • Further research into Rak's biological functions may lead to novel cancer therapies.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: